INTERCOSTAL NERVE BLOCK: Efficacy of CINB for Patients With Multiple Rib Fractures

Launched by ZACHARY WARRINER · Nov 29, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a treatment called Continuous Intercostal Nerve Block (CINB) to help relieve pain for patients who have multiple rib fractures. The researchers want to see if CINB, when used alongside standard pain medications (like non-steroidal anti-inflammatory drugs and opioids), is more effective than just using those standard medications alone. The trial is currently looking for participants who are at least 18 years old, have two or more rib fractures, and are willing to provide consent for the procedure.

Participants in this trial can expect to be randomly assigned to either receive the CINB treatment along with their usual pain medications or just the standard medications. It’s important to note that people who have allergies to the medications used in the study, are using an epidural catheter, or are prisoners cannot take part in this trial. Overall, this study aims to find better ways to manage pain for patients dealing with the challenges of rib fractures.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Subjects will be at least 18 years old
• • Subjects will have 2 or more identified rib fractures
• • Subjects will be willing to provide informed consent for procedure
• • Subjects will be identified as appropriate for initiation of continuous nerve block therapy for treatment of rib fracture associated pain.
• Exclusion Criteria:
• • Documented allergy to study medication
• • Epidural catheter use
• • Prisoners
• • Refusal of CINB therapy

Trial Officials